Global Pancreatic Cancer Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1023

Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer.
In May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The drug is into phase III of the clinical trials. The acquisition will enhance the therapy products for the Eli Lilly and Company.
In 2018, the global Pancreatic Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pancreatic Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pancreatic Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Roche
Pfizer
Merck
Celgene
Novartis
Amgen
Teva Pharmaceutical
PharmaCyte Biotech
Clovis Oncology

Market segment by Type, the product can be split into
Biology
Chemotherapy
Targeted Therapy
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pancreatic Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Pancreatic Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pancreatic Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pancreatic Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Biology
1.4.3 Chemotherapy
1.4.4 Targeted Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Pancreatic Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pancreatic Cancer Therapeutics Market Size
2.2 Pancreatic Cancer Therapeutics Growth Trends by Regions
2.2.1 Pancreatic Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Pancreatic Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pancreatic Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Pancreatic Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Pancreatic Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pancreatic Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Pancreatic Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Pancreatic Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Pancreatic Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pancreatic Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Pancreatic Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Pancreatic Cancer Therapeutics Market Size (2014-2019)
5.2 Pancreatic Cancer Therapeutics Key Players in United States
5.3 United States Pancreatic Cancer Therapeutics Market Size by Type
5.4 United States Pancreatic Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Pancreatic Cancer Therapeutics Market Size (2014-2019)
6.2 Pancreatic Cancer Therapeutics Key Players in Europe
6.3 Europe Pancreatic Cancer Therapeutics Market Size by Type
6.4 Europe Pancreatic Cancer Therapeutics Market Size by Application

7 China
7.1 China Pancreatic Cancer Therapeutics Market Size (2014-2019)
7.2 Pancreatic Cancer Therapeutics Key Players in China
7.3 China Pancreatic Cancer Therapeutics Market Size by Type
7.4 China Pancreatic Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Pancreatic Cancer Therapeutics Market Size (2014-2019)
8.2 Pancreatic Cancer Therapeutics Key Players in Japan
8.3 Japan Pancreatic Cancer Therapeutics Market Size by Type
8.4 Japan Pancreatic Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pancreatic Cancer Therapeutics Market Size (2014-2019)
9.2 Pancreatic Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Pancreatic Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Pancreatic Cancer Therapeutics Market Size by Application

10 India
10.1 India Pancreatic Cancer Therapeutics Market Size (2014-2019)
10.2 Pancreatic Cancer Therapeutics Key Players in India
10.3 India Pancreatic Cancer Therapeutics Market Size by Type
10.4 India Pancreatic Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Pancreatic Cancer Therapeutics Market Size (2014-2019)
11.2 Pancreatic Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Pancreatic Cancer Therapeutics Market Size by Type
11.4 Central & South America Pancreatic Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pancreatic Cancer Therapeutics Introduction
12.1.4 Eli Lilly Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pancreatic Cancer Therapeutics Introduction
12.2.4 Roche Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pancreatic Cancer Therapeutics Introduction
12.3.4 Pfizer Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pancreatic Cancer Therapeutics Introduction
12.4.4 Merck Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pancreatic Cancer Therapeutics Introduction
12.5.4 Celgene Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pancreatic Cancer Therapeutics Introduction
12.6.4 Novartis Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Amgen
12.7.1 Amgen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pancreatic Cancer Therapeutics Introduction
12.7.4 Amgen Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.7.5 Amgen Recent Development
12.8 Teva Pharmaceutical
12.8.1 Teva Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pancreatic Cancer Therapeutics Introduction
12.8.4 Teva Pharmaceutical Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.8.5 Teva Pharmaceutical Recent Development
12.9 PharmaCyte Biotech
12.9.1 PharmaCyte Biotech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pancreatic Cancer Therapeutics Introduction
12.9.4 PharmaCyte Biotech Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.9.5 PharmaCyte Biotech Recent Development
12.10 Clovis Oncology
12.10.1 Clovis Oncology Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pancreatic Cancer Therapeutics Introduction
12.10.4 Clovis Oncology Revenue in Pancreatic Cancer Therapeutics Business (2014-2019)
12.10.5 Clovis Oncology Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details